# Role of Insulin Action in Psoriasis Pathogenesis

> **NCT06242847** · — · TERMINATED · sponsor: **Columbia University** · enrollment: 10 (actual)

## Conditions studied

- Psoriasis
- Plaque Psoriasis
- Insulin Resistance
- PreDiabetes
- Overweight and Obesity

## Interventions

- **DIAGNOSTIC_TEST:** Oral glucose tolerance test (OGTT)
- **PROCEDURE:** Skin punch biopsy

## Key facts

- **NCT ID:** NCT06242847
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-02-02
- **Primary completion:** 2025-11-12
- **Final completion:** 2025-11-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** The study's collaborating dermatologist left the institution, and so skin biopsies could no longer be performed.
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06242847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06242847, "Role of Insulin Action in Psoriasis Pathogenesis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06242847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*